Adalimumab (Humira) Prefilled Syringe from Japan
Adalimumab is a fully human monoclonal antibody inhibiting TNF-alpha, for rheumatoid arthritis and Crohn's disease. It qualifies for HTS 3002.15.00.11 as a measured-dose immunological product for retail sale, regulating immune processes per chapter notes.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Secure prior FDA notice and biologics import license; validate TNF-targeting mechanism in docs
• Use insulated packaging with temperature monitors; declare exact measured doses per syringe